1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2.
Research Methodology
2.1.
Objective of the Study
2.2.
Baseline Methodology
2.3.
Key Industry Partners
2.4.
Major Association and Secondary Sources
2.5.
Forecasting Methodology
2.6.
Data Triangulation & Validation
2.7.
Assumptions and Limitations
3.
Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4.
Voice of Customer
5.
Global Phenylalanine
Market Outlook
5.1. Market Size & Forecast
5.1.1.
By Value
5.2. Market Share & Forecast
5.2.1.
By Type (L-Phenylalanine, D-Phenylalanine,
DL-Phenylalanine)
5.2.2.
By
Application (Depression, Attention Deficit Disorder, Parkinson disease, Chronic
Pain, Vitiligo, Others)
5.2.3.
By
End-Users (Food and Beverage, Dietary Supplements, Pharmaceuticals, Others)
5.2.4. By
Region (North America, Europe, Asia Pacific, South America, Middle East &
Africa)
5.2.5. By
Company (2022)
5.3. Market Map
5.3.1
By Type
5.3.2 By Application
5.3.3
By End-Users
5.3.4 By Region
6.
North America
Phenylalanine Market Outlook
6.1. Market Size & Forecast
6.1.1.
By Value
6.2. Market Share & Forecast
6.2.1. By Type
(L-Phenylalanine, D-Phenylalanine, DL-Phenylalanine)
6.2.2.
By
Application (Depression, Attention Deficit Disorder, Parkinson disease, Chronic
Pain, Vitiligo, Others)
6.2.3.
By
End-Users (Food and Beverage, Dietary Supplements, Pharmaceuticals, Others)
6.2.4.
By Country
6.3. North America: Country Analysis
6.3.1.
United States
Phenylalanine Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Type
6.3.1.2.2.
By Application
6.3.1.2.3.
By
End-Users
6.3.2.
Canada Phenylalanine
Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Type
6.3.2.2.2.
By Application
6.3.2.2.3.
By
End-Users
6.3.3.
Mexico Phenylalanine
Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Type
6.3.3.2.2.
By Application
6.3.3.2.3.
By
End-Users
7.
Europe Phenylalanine
Market Outlook
7.1. Market Size & Forecast
7.1.1.
By Value
7.2. Market Share & Forecast
7.2.1.
By Type (L-Phenylalanine, D-Phenylalanine,
DL-Phenylalanine)
7.2.2.
By
Application (Depression, Attention Deficit Disorder, Parkinson disease, Chronic
Pain, Vitiligo, Others)
7.2.3.
By End-Users
(Food and Beverage, Dietary Supplements, Pharmaceuticals, Others)
7.2.4.
By Country
7.3. Europe: Country Analysis
7.3.1.
France Phenylalanine
Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Type
7.3.1.2.2.
By Application
7.3.1.2.3.
By
End-Users
7.3.2.
Germany Phenylalanine
Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Type
7.3.2.2.2.
By Application
7.3.2.2.3.
By
End-Users
7.3.3.
United Kingdom
Phenylalanine Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Type
7.3.3.2.2.
By Application
7.3.3.2.3.
By End-Users
7.3.4.
Italy Phenylalanine
Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Type
7.3.4.2.2.
By Application
7.3.4.2.3.
By
End-Users
7.3.5.
Spain Phenylalanine
Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Type
7.3.5.2.2.
By Application
7.3.5.2.3.
By
End-Users
8.
Asia-Pacific
Phenylalanine Market Outlook
8.1. Market Size & Forecast
8.1.1.
By Value
8.2. Market Share & Forecast
8.2.1.
By Type (L-Phenylalanine, D-Phenylalanine,
DL-Phenylalanine)
8.2.2.
By
Application (Depression, Attention Deficit Disorder, Parkinson disease, Chronic
Pain, Vitiligo, Others)
8.2.3.
By
End-Users (Food and Beverage, Dietary Supplements, Pharmaceuticals, Others)
8.2.4.
By Country
8.3. Asia-Pacific: Country Analysis
8.3.1.
China Phenylalanine
Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Type
8.3.1.2.2.
By Application
8.3.1.2.3.
By
End-Users
8.3.2.
India Phenylalanine
Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Type
8.3.2.2.2.
By Application
8.3.2.2.3.
By
End-Users
8.3.3.
Japan Phenylalanine
Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Type
8.3.3.2.2.
By Application
8.3.3.2.3.
By
End-Users
8.3.4.
South Korea
Phenylalanine Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Type
8.3.4.2.2.
By Application
8.3.4.2.3.
By
End-Users
8.3.5.
Australia
Phenylalanine Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Type
8.3.5.2.2.
By Application
8.3.5.2.3.
By
End-Users
9.
South America
Phenylalanine Market Outlook
9.1. Market Size & Forecast
9.1.1.
By Value
9.2. Market Share & Forecast
9.2.1.
By Type (L-Phenylalanine, D-Phenylalanine,
DL-Phenylalanine)
9.2.2.
By
Application (Depression, Attention Deficit Disorder, Parkinson disease, Chronic
Pain, Vitiligo, Others)
9.2.3.
By
End-Users (Food and Beverage, Dietary Supplements, Pharmaceuticals, Others)
9.2.4.
By Country
9.3. South America: Country Analysis
9.3.1.
Brazil Phenylalanine
Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Type
9.3.1.2.2.
By Application
9.3.1.2.3.
By
End-Users
9.3.2.
Argentina
Phenylalanine Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Type
9.3.2.2.2.
By Application
9.3.2.2.3.
By
End-Users
9.3.3.
Colombia
Phenylalanine Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Type
9.3.3.2.2.
By Application
9.3.3.2.3.
By
End-Users
10.
Middle East and
Africa Phenylalanine Market Outlook
10.1.
Market Size &
Forecast
10.1.1.
By Value
10.2.
Market Share &
Forecast
10.2.1.
By Type (L-Phenylalanine, D-Phenylalanine,
DL-Phenylalanine)
10.2.2.
By
Application (Depression, Attention Deficit Disorder, Parkinson disease, Chronic
Pain, Vitiligo, Others)
10.2.3.
By
End-Users (Food and Beverage, Dietary Supplements, Pharmaceuticals, Others)
10.2.4.
By Country
10.3.
MEA: Country
Analysis
10.3.1.
South Africa
Phenylalanine Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Type
10.3.1.2.2.
By Application
10.3.1.2.3.
By
End-Users
10.3.2.
Saudi Arabia
Phenylalanine Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Type
10.3.2.2.2.
By Application
10.3.2.2.3.
By
End-Users
10.3.3.
UAE Phenylalanine
Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By Type
10.3.3.2.2.
By Application
10.3.3.2.3.
By
End-Users
11. Market Dynamics
11.1.
Drivers
11.2.
Challenges
12. Market Trends & Developments
12.1.
Recent Development
12.2.
Mergers &
Acquisitions
12.3.
Product Launches
13.
Global Phenylalanine Market: SWOT Analysis
14.
Porter’s Five Forces Analysis
14.1.
Competition in the
Industry
14.2.
Potential of New
Entrants
14.3.
Power of Suppliers
14.4.
Power of Customers
14.5.
Threat of Substitute
Products
15. Competitive Landscape
15.1.
Ajinomoto Co., Inc.
15.1.1.
Business Overview
15.1.2.
Product Offerings
15.1.3.
Recent Developments
15.1.4.
Financials (As
Reported)
15.1.5.
Key Personnel
15.1.6.
SWOT Analysis
15.2.
DAESANG
15.3.
Livzon
15.4.
KYOWA HAKKO BIO CO.,
LTD.
15.5.
Amazing Nutrition
15.6.
AMINO GmbH
15.7.
Wuxi Jinghai Amino
Acid Co., Ltd.
15.8.
Shijiazhuang Jirong
Pharmaceutical Co., Ltd.
15.9.
Shijiazhuang Haitian
Amino Acid Co., Ltd.
16. Strategic Recommendations